NV
Nicholas Vogelzang
Hematology & Oncology
Credentials: · ·
History
- 1974–1977
Internal Medicine

Research
Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma
New England Journal of Medicine · 2017 · 2,802 citations
Journal of Clinical Oncology · 2003 · First of 12 authors · Corresponding · 2,432 citations
Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer
New England Journal of Medicine · 2015 · 2,355 citations

62 papers · 7 as a fellow

61 papers · 6 as a fellow

41 papers

34 papers

33 papers

33 papers

33 papers

28 papers
